Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 18 , ISSUE 2 ( February, 2014 ) > List of Articles

RESEARCH ARTICLE

Intensive care unit acquired weakness in children: Critical illness polyneuropathy and myopathy

Praveen Khilnani, Mosharraf Shamim, Vinay Kukreti

Keywords : Children, critical illness myopathy, critical illness polyneuropathy, intensive care unit acquired weakness, intensive care unit, pediatric

Citation Information : Khilnani P, Shamim M, Kukreti V. Intensive care unit acquired weakness in children: Critical illness polyneuropathy and myopathy. Indian J Crit Care Med 2014; 18 (2):95-101.

DOI: 10.4103/0972-5229.126079

License: CC BY-ND 3.0

Published Online: 01-02-2014

Copyright Statement:  Copyright © 2014; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background and Aims: Intensive care unit acquired weakness (ICUAW) is a common occurrence in patients who are critically ill. It is most often due to critical illness polyneuropathy (CIP) or to critical illness myopathy (CIM). ICUAW is increasingly being recognized partly as a consequence of improved survival in patients with severe sepsis and multi-organ failure, partly related to commonly used agents such as steroids and muscle relaxants. There have been occasional reports of CIP and CIM in children, but little is known about their prevalence or clinical impact in the pediatric population. This review summarizes the current understanding of pathophysiology, clinical presentation, diagnosis and treatment of CIP and CIM in general with special reference to published literature in the pediatric age group. Subjects and Methods: Studies were identified through MedLine and Embase using relevant MeSH and Key words. Both adult and pediatric studies were included. Results: ICUAW in children is a poorly described entity with unknown incidence, etiology and unclear long-term prognosis. Conclusions: Critical illness polyneuropathy and myopathy is relatively rare, but clinically significant sequelae of multifactorial origin affecting morbidity, length of intensive care unit (ICU) stay and possibly mortality in critically ill children admitted to pediatric ICU.


PDF Share
  1. Bolton CF. The discovery of critical illness polyneuropathy. Eur J Anaesthesiol Suppl 2008;42:66-7.
  2. Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 1984;47:1223-31.
  3. Bednarik J, Lukas Z, Vondracek P. Critical illness polyneuromyopathy: The electrophysiological components of a complex entity. Intensive Care Med 2003;29:1505-14.
  4. De Letter MA, van Doorn PA, Savelkoul HF, Laman JD, Schmitz PI, Op de Coul AA, et al. Critical illness polyneuropathy and myopathy (CIPNM): Evidence for local immune activation by cytokine-expression in the muscle tissue. J Neuroimmunol 2000;106:206-13.
  5. Chetaille P, Paut O, Fraisse A, Kreitmann B, Camboulives J, Pellissier JF. Acute myopathy of intensive care in a child after heart transplantation. Can J Anaesth 2000;47:342-6.
  6. Sheth RD, Pryse-Phillips WE, Riggs JE, Bodensteiner JB. Critical illness neuromuscular disease in children manifested as ventilatory dependence. J Pediatr 1995;126:259-61.
  7. Tabarki B, Coffiniéres A, Van Den Bergh P, Huault G, Landrieu P, Sébire G. Critical illness neuromuscular disease: Clinical, electrophysiological, and prognostic aspects. Arch Dis Child 2002;86:103-7.
  8. Kaplan PW, Rocha W, Sanders DB, D′Souza B, Spock A. Acute steroid-induced tetraplegia following status asthmaticus. Pediatrics 1986;78:121-3.
  9. Dimachkie MM, Austin SG, Slopis JM, Vriesendorp FJ. Critical illness polyneuropathy in adolescence. J Child Neurol 1995;10:409-11.
  10. Vondracek P, Bednarik J. Clinical and electrophysiological findings and long-term outcomes in paediatric patients with critical illness polyneuromyopathy. Eur J Paediatr Neurol 2006;10:176-81.
  11. Ohto T, Iwasaki N, Ohkoshi N, Aoki T, Ichinohe M, Tanaka R, et al. A pediatric case of critical illness polyneuropathy: Clinical and pathological findings. Brain Dev 2005;27:535-8.
  12. Zifko UA, Zipko HT, Bolton CF. Clinical and electrophysiological findings in critical illness polyneuropathy. J Neurol Sci 1998;159:186-93.
  13. Tsao CY, Lo WD, Mendell JR, Batley RJ. Critical illness polyneuropathy in a 2-year-old girl with hemorrhagic shock encephalopathy syndrome. J Child Neurol 1995;10:486-8.
  14. Geller TJ, Kaiboriboon K, Fenton GA, Hayat GR. Vecuronium-associated axonal motor neuropathy: A variant of critical illness polyneuropathy? Neuromuscul Disord 2001;11:579-82.
  15. Adamovic T, Willems A, Vanasse M, D′Anjou G, Robitaille Y, Litalien C, et al. Critical illness polyneuromyopathy in a child with severe demyelinating myelitis. J Child Neurol 2009;24:758-62.
  16. Petersen B, Schneider C, Strassburg HM, Schrod L. Critical illness neuropathy in pediatric intensive care patients. Pediatr Neurol 1999;21:749-53.
  17. Banwell BL, Mildner RJ, Hassall AC, Becker LE, Vajsar J, Shemie SD. Muscle weakness in critically ill children. Neurology 2003;61:1779-82.
  18. De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, et al. Paresis acquired in the intensive care unit: A prospective multicenter study. JAMA 2002;288:2859-67.
  19. Witt NJ, Zochodne DW, Bolton CF, Grand′Maison F, Wells G, Young GB, et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 1991;99:176-84.
  20. Tepper M, Rakic S, Haas JA, Woittiez AJ. Incidence and onset of critical illness polyneuropathy in patients with septic shock. Neth J Med 2000;56:211-4.
  21. Williams S, Horrocks IA, Ouvrier RA, Gillis J, Ryan MM. Critical illness polyneuropathy and myopathy in pediatric intensive care: A review. Pediatr Crit Care Med 2007;8:18-22.
  22. Bednarík J, Vondracek P, Dusek L, Moravcova E, Cundrle I. Risk factors for critical illness polyneuromyopathy. J Neurol 2005;252:343-51.
  23. Visser LH. Critical illness polyneuropathy and myopathy: Clinical features, risk factors and prognosis. Eur J Neurol 2006;13:1203-12.
  24. Hough CL, Needham DM. The role of future longitudinal studies in ICU survivors: Understanding determinants and pathophysiology of weakness and neuromuscular dysfunction. Curr Opin Crit Care 2007;13:489-96.
  25. Young GB. Critical illness myopathy: Deeper insights. Crit Care Med 2008;36:1977.
  26. Danon MJ, Carpenter S. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991;14:1131-9.
  27. Amaya-Villar R, Garnacho-Montero J, García-Garmendía JL, Madrazo-Osuna J, Garnacho-Montero MC, Luque R, et al. Steroid-induced myopathy in patients intubated due to exacerbation of chronic obstructive pulmonary disease. Intensive Care Med 2005;31:157-61.
  28. Coakley JH, Nagendran K, Yarwood GD, Honavar M, Hinds CJ. Patterns of neurophysiological abnormality in prolonged critical illness. Intensive Care Med 1998;24:801-7.
  29. de Letter MA, Schmitz PI, Visser LH, Verheul FA, Schellens RL, Op de Coul DA, et al. Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 2001;29:2281-6.
  30. Deconinck N, Van Parijs V, Beckers-Bleukx G, Van den Bergh P. Critical illness myopathy unrelated to corticosteroids or neuromuscular blocking agents. Neuromuscul Disord 1998;8:186-92.
  31. Garnacho-Montero J, Madrazo-Osuna J, García-Garmendia JL, Ortiz-Leyba C, Jiménez-Jiménez FJ, Barrero-Almodóvar A, et al. Critical illness polyneuropathy: Risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 2001;27:1288-96.
  32. Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005;64:1348-53.
  33. Latronico N, Rasulo FA. Presentation and management of ICU myopathy and neuropathy. Curr Opin Crit Care 2010;16:123-7.
  34. Chambers MA, Moylan JS, Reid MB. Physical inactivity and muscle weakness in the critically ill. Crit Care Med 2009;37:S337-46.
  35. Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G. Clinical review: Critical illness polyneuropathy and myopathy. Crit Care 2008;12:238.
  36. Zochodne DW, Bolton CF, Wells GA, Gilbert JJ, Hahn AF, Brown JD, et al. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain 1987;110:819-41.
  37. Maher J, Rutledge F, Remtulla H, Parkes A, Bernardi L, Bolton CF. Neuromuscular disorders associated with failure to wean from the ventilator. Intensive Care Med 1995;21:737-43.
  38. Eriksson LI. Acquired neuromuscular disorders in the critically ill patient. Semin Anesth Perioper Med Pain 2002;21:135-9.
  39. Bolton CF, Laverty DA, Brown JD, Witt NJ, Hahn AF, Sibbald WJ. Critically ill polyneuropathy: Electrophysiological studies and differentiation from Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1986;49:563-73.
  40. Fenzi F, Latronico N, Refatti N, Rizzuto N. Enhanced expression of E-selectin on the vascular endothelium of peripheral nerve in critically ill patients with neuromuscular disorders. Acta Neuropathol 2003;106:75-82.
  41. Dos Santos CC, Batt J. ICU-acquired weakness: Mechanisms of disability. Curr Opin Crit Care 2012;18:509-17.
  42. Latronico N, Peli E, Botteri M. Critical illness myopathy and neuropathy. Curr Opin Crit Care 2005;11:126-32.
  43. Bolton CF. Neuromuscular manifestations of critical illness. Muscle Nerve 2005;32:140-63.
  44. Klaude M, Fredriksson K, Tjäder I, Hammarqvist F, Ahlman B, Rooyackers O, et al. Proteasome proteolytic activity in skeletal muscle is increased in patients with sepsis. Clin Sci (Lond) 2007;112:499-506.
  45. Tiao G, Hobler S, Wang JJ, Meyer TA, Luchette FA, Fischer JE, et al. Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. J Clin Invest 1997;99:163-8.
  46. Showalter CJ, Engel AG. Acute quadriplegic myopathy: Analysis of myosin isoforms and evidence for calpain-mediated proteolysis. Muscle Nerve 1997;20:316-22.
  47. Mukhopadhyay D, Riezman H. Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science 2007;315:201-5.
  48. Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction. Physiol Rev 2002;82:373-428.
  49. Constantin D, McCullough J, Mahajan RP, Greenhaff PL. Novel events in the molecular regulation of muscle mass in critically ill patients. J Physiol 2011;589:3883-95.
  50. Rich MM, Pinter MJ. Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy. J Physiol 2003;547:555-66.
  51. Rossignol B, Gueret G, Pennec JP, Morel J, Giroux-Metges MA, Talarmin H, et al. Effects of chronic sepsis on the voltage-gated sodium channel in isolated rat muscle fibers. Crit Care Med 2007;35:351-7.
  52. Capasso M, Di Muzio A, Pandolfi A, Pace M, Di Tomo P, Ragno M, et al. Possible role for nitric oxide dysregulation in critical illness myopathy. Muscle Nerve 2008;37:196-202.
  53. Zink W, Kaess M, Hofer S, Plachky J, Zausig YA, Sinner B, et al. Alterations in intracellular Ca2+-homeostasis of skeletal muscle fibers during sepsis. Crit Care Med 2008;36:1559-63.
  54. Kleyweg RP, van der Meché FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 1991;14:1103-9.
  55. Seghelini E. Direct stimulation: A useful technique. Eur J Anaesthesiol Suppl 2008;42:181-5.
  56. Maramattom BV, Wijdicks EF. Acute neuromuscular weakness in the intensive care unit. Crit Care Med 2006;34:2835-41.
  57. Zink W, Kollmar R, Schwab S. Critical illness polyneuropathy and myopathy in the intensive care unit. Nat Rev Neurol 2009;5:372-9.
  58. Hermans G, Schrooten M, Van Damme P, Berends N, Bouckaert B, De Vooght W, et al. Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: A retrospective study. Crit Care 2009;13:R5.
  59. Hermans G, Wilmer A, Meersseman W, Milants I, Wouters PJ, Bobbaers H, et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 2007;175:480-9.
  60. Griffiths RD, Palmer TE, Helliwell T, MacLennan P, MacMillan RR. Effect of passive stretching on the wasting of muscle in the critically ill. Nutrition 1995;11:428-32.
  61. Gupta K, Gupta VK, Jayashree M, Singhi S. Randomized controlled trial of interrupted versus continuous sedative infusions in ventilated children. Pediatr Crit Care Med 2012;13:131-5.
  62. Vet NJ, Verlaat CW, de Wildt SN, Tibboel D, de Hoog M. Daily interruption of sedation in critically ill children. Pediatr Crit Care Med 2012;13:122.
  63. Guarneri B, Bertolini G, Latronico N. Long-term outcome in patients with critical illness myopathy or neuropathy: The Italian multicentre CRIMYNE study. J Neurol Neurosurg Psychiatry 2008;79:838-41.
  64. Intensive care unit acquired weakness in children:Critical illness polyneuropathy and myopathy. Indian J Crit care med 2014;18:36-42
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.